Andy Tu

Revisiting Criteria for Plant MicroRNA Annotation in the Era of Big Data

The molecular hallmarks of epigenetic control

Regulation of microRNA function in animals

Chimeric Antigen Receptors With Mutated IgG4 Fc Spacer Avoid Fc Receptor Binding and Improve T Cell Persistence and Antitumor Efficacy

The expanding world of small RNAs in plants

Long Noncoding RNAs in Cancer Pathways

A Structural Perspective on Readout of Epigenetic Histone and DNA Methylation Marks

A SWI/SNF Chromatin-Remodeling Complex Acts in Noncoding RNA-Mediated Transcriptional Silencing

Inflammation and tumor progression: signaling pathways and targeted intervention

Programming CAR-T cells to kill cancer

mRNA transcript therapy

Structural and Functional Coordination of DNA and Histone Methylation

CAR-T cell therapy: current limitations and potential strategies

Clay nanosheets for topical delivery of RNAi for sustained protection against plant viruses

Cornerstones of CRISPR–Cas in drug discovery and therapy

Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

Nanotechnology for Plant Disease Management

Antibody-modified T cells: CARs take the front seat for hematologic malignancies

miRBase: from microRNA sequences to function

CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies

DDR complex facilitates global association of RNA polymerase V to promoters and evolutionarily young transposons

Dual Binding of Chromomethylase Domains to H3K9me2-Containing Nucleosomes Directs DNA Methylation in Plants

Modification of Hematopoietic Stem/Progenitor Cells with CD19-Specific Chimeric Antigen Receptors as a Novel Approach for Cancer Immunotherapy

Pre-clinical development of gene modification of haematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy